Imagion Biosystems (ASX: $ICG) has released its quarterly cash flow report in accordance with accounting standards and policies that comply with Listing Rule 19.11A. The report provides a true and fair view of the entity's activities for the past quarter, how they have been financed, and the effect on its cash position. The report is dated 8 April 2024 and has been authorized by Emma Curnow, Company Secretary, on behalf of the Board of Directors.
Imagion Biosystems (ASX: $ICG) has submitted its quarterly cash flow report, demonstrating compliance with ASX Listing Rules. The report offers a comprehensive view of the entity's activities, financing, and cash position for the past quarter. As of 8 April 2024, the report has been authorized by Emma Curnow, Company Secretary, on behalf of the Board of Directors. The report aligns with accounting standards and policies, providing transparency and insight into Imagion Biosystems' financial performance.